Hi , Biology is a powerful tool, limited only by our imagination. So why limit technologies like cultured meat to burgers and chicken? What about leather and wool? Today we bring you stories of outside-of-the-box entrepreneurs, plant-based, sushi-grade tuna, Wall Street’s growing affirmation of bio-based platform companies and much more: We can’t wait to be together with you IN PERSON!
Join us today for the Built with Biology show on Twitter Spaces at 8 am PT! Spaces is an audio-only platform—all you need is a Twitter handle and the Twitter app on your phone. Today’s guests include Saul Kato and Sharath Hegde, the CEO and CTO of Herophilus!
An Intro For the Bio-curious with SynBioBeta’s John Cumbers
Biology is changing the world and we want the world to know it! Do you know someone who is curious about synthetic biology, interested in learning about
the industry or who wants to find their next career? Here’s a great way to get started: Register now for an interactive Zoom course "An Introduction to Synthetic Biology” starting today at 9 am PT.
SynBioBeta: In-Depth
Is Tissue Engineering The Future of Cruelty-Free Fashion? Chicken, fish, and beef are fairly obvious uses of cell-culture technology - why raise and slaughter animals when you can simply grow the cells in a lab? But what about other animal products like leathers and furs? These materials are notoriously linked to animal cruelty and environmental pollution. See how two startups are taking on sustainable fashion with cultured leather, wool and fur.
John Cumbers for Forbes
Sustainable Tuna Becomes A Reality On World Ocean Day To celebrate World Oceans Day, Finless Foods, a company that makes plant-based and cell-cultured seafood alternatives, announced its new plant-based tuna product that offers a way for consumers to support healthy oceans. The new product will be available through restaurants and foodservice channels by 2022.
Science News
New approach to rewriting bacteria’s genetic code could lead to novel medicines: By rewriting the genome of Escherichia coli, researchers incorporated several unnatural amino acids into bacterial proteins.
Wall Street wins signal the start of a synthetic biology revolution: In addition to winning fans on Wall Street, synthetic biology startups have enjoyed rapidly falling costs and fresh demand from clients in emerging tech fields ranging from agriculture to drug discovery. All of this has helped to spark fresh venture capital interest.
